Nobel Prize awarded for uncovering how the immune system enforces 'peripheral immune tolerance' via regulatory T cells, opening new therapies for autoimmune diseases, cancer and transplant rejection.
Fintech, AI, and dividend-paying tech stocks are in focus as U.S. markets show sectoral rotation, with formerly unprofitable names like SoFi and Robinhood turning profitable and AI-driven lenders and platforms poised to benefit from expected Fed rate cuts.
Nobel Prize awarded for uncovering how the immune system enforces 'peripheral immune tolerance' via regulatory T cells, opening new therapies for autoimmune diseases, cancer and transplant rejection.
Fintech, AI, and dividend-paying tech stocks are in focus as U.S. markets show sectoral rotation, with formerly unprofitable names like SoFi and Robinhood turning profitable and AI-driven lenders and platforms poised to benefit from expected Fed rate cuts.